Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma

G. Fiaschetti, D. Castelletti, S. Zoller, A. Schramm, C. Schroeder, M. Nagaishi, D. Stearns, M. Mittelbronn, A. Eggert, F. Westermann, H. Ohgaki, T. Shalaby, M. Pruschy, A. Arcaro, M. A. Grotzer

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)


Medulloblastoma (MB) is the most common malignant brain tumor in children. It is known that overexpression and/or amplification of the MYC oncogene is associated with poor clinical outcome, but the molecular mechanisms and the MYC downstream effectors in MB remain still elusive. Besides contributing to elucidate how progression of MB takes place, most importantly, the identification of novel MYC-target genes will suggest novel candidates for targeted therapy in MB. A group of 209 MYC-responsive genes was obtained from a complementary DNA microarray analysis of a MB-derived cell line, following MYC overexpression and silencing. Among the MYC-responsive genes, we identified the members of the bone morphogenetic protein (BMP) signaling pathway, which have a crucial role during the development of the cerebellum. In particular, the gene BMP7 was identified as a direct target of MYC. A positive correlation between MYC and BMP7 expression was documented by analyzing two distinct sets of primary MB samples. Functional studies in vitro using a small-molecule inhibitor of the BMP/SMAD signaling pathway reproduced the effect of the small interfering RNA-mediated silencing of BMP7. Both approaches led to a block of proliferation in a panel of MB cells and to inhibition of SMAD phosphorylation. Altogether, our findings indicate that high MYC levels drive BMP7 overexpression, promoting cell survival in MB cells. This observation suggests the potential relevance of targeting the BMP/SMAD pathway as a novel therapeutic approach for the treatment of childhood MB.

Original languageEnglish
Pages (from-to)2823-2835
Number of pages13
Issue number25
Publication statusPublished - 23 Jun 2011
Externally publishedYes


  • BMP7
  • MYC
  • brain tumor
  • medulloblastoma
  • pediatric cancer


Dive into the research topics of 'Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma'. Together they form a unique fingerprint.

Cite this